GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,649,000 | -27.7% | 37,884 | -27.7% | 0.01% | -7.1% |
| Q1 2022 | $2,282,000 | -17.9% | 52,370 | -16.9% | 0.01% | 0.0% |
| Q4 2021 | $2,779,000 | +29.1% | 63,017 | +11.9% | 0.01% | +7.7% |
| Q3 2021 | $2,152,000 | +2.7% | 56,307 | +7.0% | 0.01% | +8.3% |
| Q2 2021 | $2,096,000 | +18.1% | 52,621 | +5.9% | 0.01% | 0.0% |
| Q1 2021 | $1,775,000 | -10.8% | 49,712 | -8.1% | 0.01% | 0.0% |
| Q4 2020 | $1,990,000 | -2.0% | 54,072 | +0.2% | 0.01% | -20.0% |
| Q3 2020 | $2,031,000 | -20.8% | 53,953 | -14.2% | 0.02% | -25.0% |
| Q2 2020 | $2,565,000 | +10.5% | 62,882 | +2.7% | 0.02% | -13.0% |
| Q1 2020 | $2,321,000 | -25.5% | 61,252 | -7.6% | 0.02% | 0.0% |
| Q4 2019 | $3,115,000 | +9.7% | 66,292 | -0.4% | 0.02% | 0.0% |
| Q3 2019 | $2,840,000 | -8.6% | 66,540 | -14.3% | 0.02% | -8.0% |
| Q2 2019 | $3,108,000 | -27.6% | 77,681 | -24.4% | 0.02% | -28.6% |
| Q1 2019 | $4,294,000 | -2.5% | 102,757 | -10.8% | 0.04% | -5.4% |
| Q4 2018 | $4,402,000 | -27.6% | 115,193 | -23.9% | 0.04% | -7.5% |
| Q3 2018 | $6,080,000 | -2.7% | 151,349 | -2.4% | 0.04% | -4.8% |
| Q2 2018 | $6,249,000 | +3.8% | 155,008 | +0.6% | 0.04% | +180.0% |
| Q1 2018 | $6,021,000 | +20.5% | 154,102 | +9.4% | 0.02% | +25.0% |
| Q4 2017 | $4,995,000 | -41.6% | 140,840 | -33.1% | 0.01% | -40.0% |
| Q3 2017 | $8,548,000 | +5.4% | 210,549 | +11.9% | 0.02% | -4.8% |
| Q2 2017 | $8,113,000 | +6.7% | 188,167 | +4.3% | 0.02% | 0.0% |
| Q1 2017 | $7,605,000 | +5.0% | 180,434 | -4.0% | 0.02% | 0.0% |
| Q4 2016 | $7,240,000 | -23.7% | 187,998 | -14.6% | 0.02% | -30.0% |
| Q3 2016 | $9,492,000 | -3.9% | 220,064 | -3.4% | 0.03% | -3.2% |
| Q2 2016 | $9,877,000 | -11.0% | 227,905 | -16.7% | 0.03% | -11.4% |
| Q1 2016 | $11,098,000 | -2.8% | 273,689 | -3.3% | 0.04% | +6.1% |
| Q4 2015 | $11,421,000 | -9.4% | 283,034 | -13.7% | 0.03% | -15.4% |
| Q3 2015 | $12,600,000 | +39.4% | 327,801 | +51.1% | 0.04% | +77.3% |
| Q2 2015 | $9,037,000 | -57.4% | 216,903 | -52.8% | 0.02% | -56.0% |
| Q1 2015 | $21,222,000 | +73.0% | 459,854 | +60.2% | 0.05% | +61.3% |
| Q4 2014 | $12,266,000 | +6.8% | 287,025 | +14.9% | 0.03% | +10.7% |
| Q3 2014 | $11,480,000 | -50.6% | 249,698 | -42.5% | 0.03% | -52.5% |
| Q2 2014 | $23,236,000 | +139.1% | 434,539 | +138.9% | 0.06% | +110.7% |
| Q1 2014 | $9,717,000 | -52.7% | 181,913 | -52.7% | 0.03% | -54.8% |
| Q4 2013 | $20,529,000 | +12.2% | 384,518 | +5.4% | 0.06% | -6.1% |
| Q3 2013 | $18,303,000 | +6.1% | 364,865 | +5.7% | 0.07% | -9.6% |
| Q2 2013 | $17,254,000 | – | 345,304 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |